Filter by:

Project name

Lead Institution



Usher Institute, The University of Edinburgh

The Vaccine Booster Breakthroughs project (VBB) builds upon the successful, innovative work of the earlier Vaccine Breakthroughs Project.

UK Research and Innovation (as part of the COVID-19 National Core Studies)

NIHR Manchester Clinical Research Facility

This is the UK arm of a clinical trial of the vaccine (GRT-R910) produced by US-based biotechnology company Gritstone bio, Inc. 

Health Innovation Manchester

Usher Institute, University of Edinburgh

Researchers at the University of Edinburgh, in collaboration with Public Health Scotland other partners, are using patient data across Scotland to track the COVID-19 pandemic and its affected across Scotland, as well as monitor the effectiveness o

National Institute for Health Research Health Technology Assessment Programme, Medical Research Council, Scottish Government

Usher Institute, University of Edinburgh

Vaccine breakthrough is a term used to describe the SARS-CoV-2 virus ‘breaking through’ the protection given by COVID-19 vaccines. This includes first-time infections, reinfections and COVID-19 related hospitalisations and deaths.

National Core Studies Immunity Programme, UK Research and Innovation (Medical Research Council), Scottish Government, Health Data Research UK, Chief Scientist Office, National Institute for Health Research

University of Exeter
This study will investigate the impact of specific drugs and shielding on COVID-19 infection and subsequent immunity in people with inflammatory bowel disease (IBD).

National Institute for Health Research (NIHR)